Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · IEX Real-Time Price · USD
0.790
-0.045 (-5.42%)
Jul 22, 2024, 10:06 AM EDT - Market open
Sol-Gel Technologies Employees
Sol-Gel Technologies had 36 employees as of December 31, 2023. The number of employees decreased by 19 or -34.55% compared to the previous year.
Employees
36
Change (1Y)
-19
Growth (1Y)
-34.55%
Revenue / Employee
$47,778
Profits / Employee
-$635,028
Market Cap
22.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ImmunoPrecise Antibodies | 102 |
Ekso Bionics Holdings | 72 |
Biora Therapeutics | 58 |
HCW Biologics | 45 |
Apollomics | 45 |
Inspira Technologies Oxy B.H.N. | 42 |
Nephros | 31 |
BioVie | 18 |
SLGL News
- 7 days ago - Sol-Gel Technologies Announces Management Realignment - GlobeNewsWire
- 2 months ago - Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 2 months ago - Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel - GlobeNewsWire
- 4 months ago - Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream - GlobeNewsWire
- 4 months ago - Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments - GlobeNewsWire
- 8 months ago - Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study - GlobeNewsWire
- 8 months ago - Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610 - GlobeNewsWire
- 9 months ago - Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire